THE MEDICAL NEWS

In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 was 100% for genotypes 3a, 3b, 6a, and compensated cirrhosis, 93.3% for genotype 1b, and 90% for HBV co‑infection.

Understanding how obesity has been portrayed in art across the ages can make doctors more empathic and less judgmental, which should lead to their patients achieving better outcomes, new reasearch at this year's European Congress on Obesity (ECO 2026) argues.

Researchers have proposed new standards into the decades' old prosthetic donations market, improving the quality of lower limb prosthetic feet by two-thirds – a major quality of life boost for recipients.

Comparative data on sequential transarterial chemoembolization (TACE) after stereotactic body radiation therapy (SBRT) in recurrent hepatocellular carcinoma (HCC) remain limited. This study aimed to evaluate the efficacy of this combination.

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and Mediar Therapeutics (Mediar), a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced Qureight's AI-powered 3D quantitative imaging analytics platform and services will be use…

Gene editing can repair a DNA error in mice that causes Dravet syndrome, a rare, incurable, and potentially deadly form of childhood epilepsy. After the edit, the mice have far fewer seizures and live much longer.

With three people dead and 11 cases from the recent hantavirus outbreak on a cruise ship, UMD's internationally renowned expert on airborne viruses, Dr. Don Milton, joins public health colleagues in an opinion piece in the British Medical Journal (BMJ) calling on the World Health Organization (WHO) to shift its default response to emerging respiratory viruses.